Home / Health / Heart Attack Tests Miss Women: New Guidelines Urge Change
Heart Attack Tests Miss Women: New Guidelines Urge Change
4 Oct
Summary
- New guidelines address a diagnostic gap where heart attack testing historically used male-centric data.
- Women often experience different heart attack symptoms and may have lower troponin levels.
- International cardiac societies issued updated definitions to improve diagnosis and care for women.
New international guidelines are being implemented to address a significant gender gap in diagnosing heart attacks. For years, medical standards relied on research primarily derived from male patients, potentially overlooking critical differences in how women experience heart attacks. Heart disease remains the leading cause of death for women worldwide, yet their diagnostic and treatment pathways have often been based on a male standard of care.
These updated definitions, developed by a task force of international cardiac societies, acknowledge that women may exhibit different symptoms and have lower levels of troponin, a key protein released during heart damage. The previous reliance on male-normed troponin levels could lead to misdiagnosis or delayed treatment for women, as seen in the experience of Karen Humphrey, who faced skepticism and repeated dismissal before her severe heart condition was identified.
Beyond blood markers, women can experience less recognized symptoms like nausea and indigestion, contributing to diagnostic delays. Research indicates that a notable number of women are sent home from emergency departments only to return with a heart attack within 30 days. The new guidance aims to improve detection rates and ensure women are appropriately investigated, moving towards a more personalized approach to cardiovascular care.
Experts emphasize the need to treat women with specific consideration for their unique health differences. While the improved detection is a crucial step, ensuring appropriate investigation and treatment within healthcare systems remains the next challenge. The hope is that these changes will lead to fewer dismissed symptoms, more accurate diagnoses, and ultimately, better outcomes for women at risk of heart attack.
